Danaher Corporation (DHR) Price History:-8.99%(TTM)
The price cagr for Danaher Corporation (DHR) is -8.99% over the latest trailing 12-month period. The comparable SPY value is +20.75%. Year-to-date price return is -19.96%. Price CAGR uses adjusted close price history and excludes dividends.
Current Price
$184.41
$-4.03 (-2.14%)
Previous Close: $188.44
Today's Trading
- Open
- $186.96
- Day High
- $188.18
- Day Low
- $183.87
- Volume
- 1.84M
- Avg Volume
- 4.42M
52-Week Position
29%
of the 52-week price range
- From 52-week high
- -24.05%
- From 52-week low
- +14.59%
52-Week Price Range
52-Week Low
$160.93
May 15, 2026
Current Price
$184.41
29% of range
52-Week High
$242.80
Jan 21, 2026
Price Returns by Period
1 Day
-2.14%
7 Days
+3.55%
30 Days
+10.74%
YTD
-19.96%
1 Year
-8.99%
vs 52W High
-24.05%
DHR Price Chart
Long-Term Performance (CAGR)
Price CAGR (3Y)
-4.03%
Price CAGR (5Y)
-3.32%
Total Return CAGR (3Y)
-3.51%
Total Return CAGR (5Y)
-2.87%
CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.
Key Price Statistics
| Current Price | $184.41 |
| Previous Close | $188.44 |
| Day Range | $183.87 - $188.18 |
| 52-Week Range | $160.93 - $242.80 |
| Volume | 1.84M |
| Average Volume | 4.42M |
| Market Cap | $130.25B |
| % from 52W High | -24.05% |
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair